Ki67 and Salivary Cancer

REFERENCES

• Hofmann K., Bucher P. The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors. Trends Biochem Sci 1995; 20: 347–349
   PubMed Web of Science ®Google Scholar
• Schluter C., Duchrow M., Wohlenberg C., Becker M. H., Key G., Flad H. D., Gerdes J. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993; 123: 513–522
   PubMed Web of Science ®Google Scholar
• Plaat B., Kole A., Mastik M., Hoekstra H., Molenaar W., Vaalburg W. Protein synthesis rate measured with L-[1–11C]tyrosine positron emission tomography correlates with mitotic activity and MIB-1 antibody-detected proliferation in human soft tissue sarcomas. Eur J Nucl Med 1999; 26: 328–332
   PubMedGoogle Scholar
• Pich A., Chiusa L., Navone R. Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 2004; 15: 1319–1329
   PubMed Web of Science ®Google Scholar
• Brown D. C., Gatter K. C. Ki67 protein: the immaculate deception?. Histopathol 2002; 40: 2–11
   PubMed Web of Science ®Google Scholar
• van Diest P. J., van der Wall E., Baak J. P. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol 2004; 57: 675–681
   PubMed Web of Science ®Google Scholar
• Spiro R. H., Dubner S. Salivary gland tumors. Curr Opin Oncol 1990; 2: 589–595
   PubMedGoogle Scholar
• Eneroth C. M. Salivary gland tumors in the parotid gland, submandibular gland and the palate region. Cancer 1971; 27: 1415–1418
   PubMed Web of Science ®Google Scholar
• Eveson J. W., Cawson R. A. Salivary gland tumors. a review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 1985; 146: 51–58
   Google Scholar
• Nagler R. M., Barak M., Ben-Aryeh H., Peled M., Filatov M., Laufer D. Early diagnostic and treatment monitoring role of Cyfra 21–1 and TPS in oral squamous cell carcinoma. Cancer 1999; 35: 1018–1025
   Google Scholar
• Handra-Luca A., Ruhin B., Lesty C., Fouret P. P27, Skp2, and extra-cellular signal-related kinase signaling in human salivary gland mucoepidermoid carcinoma. Oral Oncol 2006; 42: 1005–1100
   PubMed Web of Science ®Google Scholar
• Katori H., Nozawa A., Tsukuda M. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma. Auris Nasus Larynx 2007; 34: 79–84
   PubMed Web of Science ®Google Scholar
• Katori H., Nozawa A., Tsukuda M. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma. Acta Otolaryngol 2007; 127: 1207–1213
   PubMed Web of Science ®Google Scholar
• Matsubayashi S., Yoshihara T. Carcinoma ex pleomorphic adenoma of the salivary gland: An immunohistochemical study. Eur Arch Otorhinolaryngol 2007; 264: 789–95
   PubMed Web of Science ®Google Scholar
• Ben-Izhak O., Laster Z., Araidy S., Nagler R. M. TUNEL – an efficient predictor of salivary malignancies. Br J Cancer 2007; 96: 1101–1106
   PubMed Web of Science ®Google Scholar
• Ben Izhak O., Kaplan-Cohen V., Ilan N., Gan S., Vlodavsky I., Nagler R. Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival. Neoplasia 2006; 8: 879–884
   PubMed Web of Science ®Google Scholar
• Nagler R., Kerner H., Laufer D., Ben-Eliezer S., Minkov I., Ben-Yizhak O. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett 2002; 2: 137–150
   Google Scholar
• Ben-Izhak O., Kablan F., Laster Z., Nagler R. M. Oropharyngeal cancer pathogenesis: ubiquitin proteolytic, apoptotic and epidermal growth factor related pathways act in concert – first report. Oral Oncol 2005; 41: 851–860
   PubMed Web of Science ®Google Scholar
• Hershko D. D., Shapira M. Prognostic role of p27 Kip1 deregulation in colorectal cancer. Cancer 2006; 107: 668–675
   PubMed Web of Science ®Google Scholar
• Kudo Y., Kitajima S., Ogawa I., Miyauchi M., Takata T. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. Oral Oncol 2005; 41: 105–116
   PubMed Web of Science ®Google Scholar
• Bloom J., Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 2003; 13: 41–47
   PubMed Web of Science ®Google Scholar
• Nakayama K. I., Hatakeyama S., Nakayama K. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27 Kip1. Biochem Biophys Res Commun 2001; 282: 853–860
   PubMed Web of Science ®Google Scholar
• Strianese D., Baldi G., Staibano S., Baldi A., De Rosa G., Tranfa F, Bonavolonta G. Expression of apoptosis-related markers in malignant epithelial tumors of the lacrimal gland and their relation to clinical outcome. Br J Ophthalmol 2007; 91: 1239–1243
   PubMed Web of Science ®Google Scholar